Evidence map›Paper›PMID 37570800›Full record

ArticleMolecules (Basel, Switzerland)2023

In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents.

Mediha Assad, Rizwan Nasir Paracha, Abu Bakar Siddique, Muhammad Ashraf Shaheen, Nadeem Ahmad, Muhammad Mustaqeem, Fariha Kanwal, Muhammad Zia Ul Mustafa, Muhammad Fayyaz Ur Rehman, Sumaya Fatima and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Mediha AssadCollege of Biological Sciences and Medical Engineering, Donghua University, 2999 North Ren Min Road, Shanghai 201620, China.
Rizwan Nasir ParachaDepartment of Chemistry, Thal University Bhakkar, Bhakkar 30000, Pakistan.ORCID 0000-0002-7138-7789
Abu Bakar SiddiqueInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0003-2834-5708
Muhammad Ashraf ShaheenInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Nadeem AhmadDepartment of Pharmacy, Comsats University Islamabad, Lahore Campus, Lahore 54000, Pakistan.
Muhammad MustaqeemInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Fariha KanwalSchool of Biomedical Engineering, Shanghai Jiaotong University, Shanghai 200030, China.
Muhammad Zia Ul MustafaInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0009-0002-0236-3991
Muhammad Fayyaz Ur RehmanInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0003-2901-7212
Sumaya FatimaResearch Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Changrui LuCollege of Biological Sciences and Medical Engineering, Donghua University, 2999 North Ren Min Road, Shanghai 201620, China.
University of Sargodha · PKCOMSATS University Islamabad · PKDonghua University · CNHebei Medical University · CNLahore College for Women University · PKShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study reports the one-step synthesis of several 3-formyl-4-hydroxycouramin-derived enamines (

Indexed as

4-HydroxycoumarinsAntineoplastic AgentsMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipVinblastine4-HydroxycoumarinsAntineoplastic AgentsVinblastineanti-tumorcoumarinenamineshydroxycoumarin

Identifiers

PMID37570800
PMCPMC10421012
OpenAlexW4385492384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.